BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18497883)

  • 1. Is CD133 a marker of metastatic colon cancer stem cells?
    LaBarge MA; Bissell MJ
    J Clin Invest; 2008 Jun; 118(6):2021-4. PubMed ID: 18497883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
    Shmelkov SV; Butler JM; Hooper AT; Hormigo A; Kushner J; Milde T; St Clair R; Baljevic M; White I; Jin DK; Chadburn A; Murphy AJ; Valenzuela DM; Gale NW; Thurston G; Yancopoulos GD; D'Angelica M; Kemeny N; Lyden D; Rafii S
    J Clin Invest; 2008 Jun; 118(6):2111-20. PubMed ID: 18497886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
    Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP
    Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential CD133 expression pattern during mouse colon tumorigenesis.
    Arena V; Caredda E; Cufino V; Stigliano E; Scaldaferri F; Gasbarrini A; Cittadini A; Sgambato A
    Anticancer Res; 2011 Dec; 31(12):4273-5. PubMed ID: 22199291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analyses of CD133 expression facilitate researches on tumor stem cells.
    Liao Y; Hu X; Huang X; He C
    Biol Pharm Bull; 2010; 33(5):738-42. PubMed ID: 20460748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell line.
    Feng JM; Miao ZH; Jiang Y; Chen Y; Li JX; Tong LJ; Zhang J; Huang YR; Ding J
    Cancer Biol Ther; 2012 Dec; 13(14):1396-406. PubMed ID: 22954703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer.
    Puglisi MA; Sgambato A; Saulnier N; Rafanelli F; Barba M; Boninsegna A; Piscaglia AC; Lauritano C; Novi ML; Barbaro F; Rinninella E; Campanale C; Giuliante F; Nuzzo G; Alfieri S; Doglietto GB; Cittadini A; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():55-62. PubMed ID: 19530513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
    Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
    Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
    Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A
    J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts.
    Zhao Y; Zhang W; Guo Z; Ma F; Wu Y; Bai Y; Gong W; Chen Y; Cheng T; Zhi F; Zhang Y; Wang J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1782-92. PubMed ID: 23877322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive in vivo imaging of tumor-associated CD133/prominin.
    Tsurumi C; Esser N; Firat E; Gaedicke S; Follo M; Behe M; Elsässer-Beile U; Grosu AL; Graeser R; Niedermann G
    PLoS One; 2010 Dec; 5(12):e15605. PubMed ID: 21187924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis.
    Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A
    J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells.
    Cui L; Ohuchida K; Mizumoto K; Moriyama T; Onimaru M; Nakata K; Nabae T; Ueki T; Sato N; Tominaga Y; Tanaka M
    PLoS One; 2010 Aug; 5(8):e12121. PubMed ID: 20711432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.